Engineers from the jet propulsion Laboratory of the National office for Aeronautics and space research (NASA) has developed a new model of artificial lungs ventilation machines for patients COVID-19. On 30 April it was approved by Management on control over products and medicines, according to the website NASA.
The new device is called VITAL, it was created to overcome the lack of medical ventilators in the United States, and use them for patients with the most severe disease.
The new device has already passed clinical trials. It is noted that VITAL going lighter than traditional models, and maintained easier.
“Designed to work for three or four months, the new device will not replace the existing hospital ventilators that can operate for many years, and is intended to address a broader range of medical issues,” added NASA.
Respiratory failure is one of the most serious complications COVID-19. In case of development of a patient connected to a ventilator. In this regard, hospitals around the world are experiencing a shortage of ventilators.
Flash coronavirus infection COVID-19 began in December 2019 in China. March 11, the world health organization declared the spread of the coronavirus pandemic.
As of the morning of 2 may throughout the world, the coronavirus has infected 3 099 344 peoplehave died from COVID-19 238 775, recovered 1 053 344.